BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 35462559)

  • 1. S-Nitrosylation of cathepsin B affects autophagic flux and accumulation of protein aggregates in neurodegenerative disorders.
    Kim KR; Cho EJ; Eom JW; Oh SS; Nakamura T; Oh CK; Lipton SA; Kim YH
    Cell Death Differ; 2022 Nov; 29(11):2137-2150. PubMed ID: 35462559
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Loss of Cathepsin B and L Leads to Lysosomal Dysfunction, NPC-Like Cholesterol Sequestration and Accumulation of the Key Alzheimer's Proteins.
    Cermak S; Kosicek M; Mladenovic-Djordjevic A; Smiljanic K; Kanazir S; Hecimovic S
    PLoS One; 2016; 11(11):e0167428. PubMed ID: 27902765
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Zinc enhances autophagic flux and lysosomal function through transcription factor EB activation and V-ATPase assembly.
    Kim KR; Park SE; Hong JY; Koh JY; Cho DH; Hwang JJ; Kim YH
    Front Cell Neurosci; 2022; 16():895750. PubMed ID: 36246521
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cathepsin B Deficiency Improves Memory Deficits and Reduces Amyloid-β in hAβPP Mouse Models Representing the Major Sporadic Alzheimer's Disease Condition.
    Hook G; Kindy M; Hook V
    J Alzheimers Dis; 2023; 93(1):33-46. PubMed ID: 36970896
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cathepsin B Gene Knockout Improves Behavioral Deficits and Reduces Pathology in Models of Neurologic Disorders.
    Hook G; Reinheckel T; Ni J; Wu Z; Kindy M; Peters C; Hook V
    Pharmacol Rev; 2022 Jul; 74(3):600-629. PubMed ID: 35710131
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cathepsin B inhibition blocks neurite outgrowth in cultured neurons by regulating lysosomal trafficking and remodeling.
    Jiang M; Meng J; Zeng F; Qing H; Hook G; Hook V; Wu Z; Ni J
    J Neurochem; 2020 Nov; 155(3):300-312. PubMed ID: 32330298
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The roles of S-nitrosylation and S-glutathionylation in Alzheimer's disease.
    Dyer RR; Ford KI; Robinson RAS
    Methods Enzymol; 2019; 626():499-538. PubMed ID: 31606089
    [TBL] [Abstract][Full Text] [Related]  

  • 8. S-Nitrosylation in Alzheimer's disease.
    Zhao QF; Yu JT; Tan L
    Mol Neurobiol; 2015 Feb; 51(1):268-80. PubMed ID: 24664522
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential S-nitrosylation of proteins in Alzheimer's disease.
    Zahid S; Khan R; Oellerich M; Ahmed N; Asif AR
    Neuroscience; 2014 Jan; 256():126-36. PubMed ID: 24157928
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inflammatory mediators leading to protein misfolding and uncompetitive/fast off-rate drug therapy for neurodegenerative disorders.
    Lipton SA; Gu Z; Nakamura T
    Int Rev Neurobiol; 2007; 82():1-27. PubMed ID: 17678953
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Free Radical-Generating System Regulates Amyloid Oligomers: Involvement of Cathepsin B.
    Llorente P; Kristen H; Sastre I; Toledano-Zaragoza A; Aldudo J; Recuero M; Bullido MJ
    J Alzheimers Dis; 2018; 66(4):1397-1408. PubMed ID: 30400084
    [TBL] [Abstract][Full Text] [Related]  

  • 12. S-Nitrosylation of DRP1 does not affect enzymatic activity and is not specific to Alzheimer's disease.
    Bossy B; Petrilli A; Klinglmayr E; Chen J; Lütz-Meindl U; Knott AB; Masliah E; Schwarzenbacher R; Bossy-Wetzel E
    J Alzheimers Dis; 2010; 20 Suppl 2(Suppl 2):S513-26. PubMed ID: 20463395
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Redox modulation by S-nitrosylation contributes to protein misfolding, mitochondrial dynamics, and neuronal synaptic damage in neurodegenerative diseases.
    Nakamura T; Lipton SA
    Cell Death Differ; 2011 Sep; 18(9):1478-86. PubMed ID: 21597461
    [TBL] [Abstract][Full Text] [Related]  

  • 14. S-nitrosylated protein-disulphide isomerase links protein misfolding to neurodegeneration.
    Uehara T; Nakamura T; Yao D; Shi ZQ; Gu Z; Ma Y; Masliah E; Nomura Y; Lipton SA
    Nature; 2006 May; 441(7092):513-7. PubMed ID: 16724068
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of autophagic flux by S-nitrosylation of SQSTM1/p62 promotes neuronal secretion and cell-to-cell transmission of SNCA/α-synuclein in Parkinson disease and Lewy body dementia.
    Oh CK; Nakamura T; Lipton SA
    Autophagy Rep; 2022; 1(1):223-225. PubMed ID: 38098743
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nitrosative Stress in the Nervous System: Guidelines for Designing Experimental Strategies to Study Protein S-Nitrosylation.
    Nakamura T; Lipton SA
    Neurochem Res; 2016 Mar; 41(3):510-4. PubMed ID: 26118537
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cathepsin B links oxidative stress to the activation of NLRP3 inflammasome.
    Bai H; Yang B; Yu W; Xiao Y; Yu D; Zhang Q
    Exp Cell Res; 2018 Jan; 362(1):180-187. PubMed ID: 29196167
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aberrant protein s-nitrosylation in neurodegenerative diseases.
    Nakamura T; Tu S; Akhtar MW; Sunico CR; Okamoto S; Lipton SA
    Neuron; 2013 May; 78(4):596-614. PubMed ID: 23719160
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of the cysteine nitrosylation sites in human endothelial nitric oxide synthase.
    Tummala M; Ryzhov V; Ravi K; Black SM
    DNA Cell Biol; 2008 Jan; 27(1):25-33. PubMed ID: 17941803
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cathepsin B inhibition ameliorates the non-alcoholic steatohepatitis through suppressing caspase-1 activation.
    Tang Y; Cao G; Min X; Wang T; Sun S; Du X; Zhang W
    J Physiol Biochem; 2018 Nov; 74(4):503-510. PubMed ID: 30019185
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.